Company intelligence / Profile preview

elephant

Ownership: Private
Development stage: Other

Overview

Green Elephant Biotech has developed and commercialized sustainable lab consumables made from plant-based plastics. Their flagship product, CellScrew®, is an innovative single-use device that enables efficient, scalable expansion of adherent cells—addressing bottlenecks in biopharmaceutical production. The company’s solutions help make advanced therapies more accessible by streamlining processes while reducing environmental impact[1][2][3][4][5][6].

Modalities: Device
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on elephant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on elephant.

Explore the full profile